Omzo vs Oak Longevity: Compare Pricing, Prescriptions, and Care
Quick verdict: Omzo vs Oak Longevity — choose Oak Longevity if your priority is lower advertised monthly pricing and no subscription; choose Omzo if you want clinician-guided plans with options that may include branded prescriptions. This comparison highlights pricing, medication sourcing and regulatory notes, clinical review process, and shipping and extras.
Explore Omzo clinician-guided plans
How Omzo and Oak Longevity differ on price and billing
Omzo lists personalized compounded semaglutide with semaglutide starting at $179 and tirzepatide starting at $279, described as clinician-guided and clinician-reviewed. Oak Longevity advertises semaglutide from $133/month and tirzepatide from $199/month with one flat price for all dosages and billing described as monthly on a non-recurring basis with no subscription. Oak explicitly states no subscriptions, no membership fees, and no hidden costs; Omzo notes pricing, eligibility, pharmacy, state coverage and renewal terms may change.
See Oak Longevity pricing and terms
Medication sourcing and regulatory notes
Both providers make compounded medications available, and both record the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo describes a Compounded Medication Program produced by state-licensed sterile compounding pharmacies and also notes providers may write prescriptions for branded medications (for which Omzo does not sell, dispense, or ship the branded product). Oak Longevity emphasizes compounded semaglutide and tirzepatide prepared by licensed compounding pharmacies and repeats the same regulatory note.
Clinical model: clinician-guided vs asynchronous review
Omzo positions its offering as clinician-guided plans reviewed by licensed U.S. providers and cautions that clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and make final prescribing decisions. Oak Longevity highlights board-certified physicians in your state who review cases, and that the process can be completed without a video call because review is asynchronous; Oak notes same-day approval is available for qualifying patients. Both emphasize clinician judgment determines eligibility and prescribing.
Check Omzo clinician-reviewed options
Shipping, extras, and patient experience differences
Oak Longevity advertises free shipping with tracking, free health coaching included with every plan, and no video call or insurance required. Oak also notes three-month prescriptions are billed upfront and that no refunds are available after physician approval and once medication has shipped. Omzo highlights fast, discreet delivery and states FSA and HSA eligibility as a feature, while also emphasizing that medication costs are included in fees collected by Omzo and that Omzo associates with certified U.S. pharmacies. Omzo includes a patient example describing reported outcomes but clarifies no guarantees.
Concise comparison table
| Criteria | Omzo | Oak Longevity |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | Semaglutide from $133/mo; tirzepatide from $199/mo |
| Medication type | Compounded semaglutide & tirzepatide; providers may prescribe branded meds | Compounded semaglutide & tirzepatide, one price covers all dosages |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
| Clinical review | Clinician-guided plans reviewed by licensed U.S. providers | Board-certified physicians review cases; asynchronous review, no video call required |
| Shipping and extras | Fast, discreet delivery; FSA & HSA eligible | Free shipping with tracking; free health coaching; no subscriptions |
| Billing model | Medication costs included in Omzo fees; terms may change | Monthly non-recurring billing; three-month prescriptions billed upfront |
Who each provider may suit
Omzo may suit people who want clinician-guided plans reviewed by licensed U.S. providers and who value options that may include prescriptions for FDA-approved branded medications, understanding Omzo does not dispense branded meds and that compounded programs are not FDA-approved. Oak Longevity may suit cost-conscious patients who want lower advertised monthly pricing, one flat price for all dosages, free shipping and coaching, and an asynchronous review process with no video call requirement.
Compare Oak Longevity plans now
Review Omzo pricing and options
Final recommendation
In summary, Omzo vs Oak Longevity centers on tradeoffs between clinician-guided, potentially broader prescribing options at Omzo and Oak Longevity’s lower advertised monthly prices, one-price-for-all-dosages approach, and included extras like free coaching and shipping. Both note compounded medications are not FDA-approved and both rely on clinician judgment for eligibility.
Choose Omzo if you want clinician-guided plans reviewed by licensed U.S. providers and the possibility your provider may write a prescription for a branded medication while understanding Omzo uses compounded medication programs that are not FDA-approved.
Choose Oak Longevity if you prioritize lower advertised monthly pricing, a one-price-for-all-dosages model with no subscription, free shipping and health coaching, and an asynchronous review that can be completed without a video call.